DfR Solutions opens European headquarters in Espoo
Life Sciences
Life Sciences in the Greater Helsinki Region boasts some impressive numbers: 5,469 enterprises, 19,697 professionals and totals 3.5 billion EUR in revenues (2007 figures of Statistics Finland). Greater Helsinki, the capital region of Finland with 1.2 million inhabitants, has an attractive base of biosciences including 9 universities, 8 universities of applied sciences and several research centers. The biocenters in the region provide an excellent research environment for scientists and incubator companies offer facilities and services for start-up companies in close vicinity to strong basic research. There are four campuses relevant to life sciences in Greater Helsinki: Viikki focuses on the biosciences, Meilahti on biomedicine, Otaniemi is a technology campus and the natural sciences are studied at Kumpula.
Finnish diabetes technology company Mendor starts co-operation in the Baltic region with Mediq
Diabetes technology growth company Mendor has made a distribution agreement in the Baltic region with …
A culture of fresh thinking, Life Sciences, R&D&I
Three Finnish Red Herring Global 100 winners
Beneq, Footbalance System and Microtask, three innovative Finnish companies, are among Red Herring Global 100 …
A culture of fresh thinking, ICT, Life Sciences, R&D&I, Skills
Eight Finnish companies nominated for Red Herring’s Top 100 Global award
Eight Finnish technology companies have been nominated for Red Herring’s Top 100 Global award, a …
A culture of fresh thinking, ICT, Life Sciences, R&D&I, Skills, Biotechnology, Nanotechnology
New ways of treating diabetes
Some innovative products have been developed in Finland for blood glucose monitoring that motivate the …
A culture of fresh thinking, Life Sciences, R&D&I
Finnish Start-up Emerges Post Merck/Schering-Plough Merger
Merck & Co Inc. (MRK) out-licensed a portfolio of gene therapy products into a new …
A culture of fresh thinking, Life Sciences, Neuroscience
China Finland VC Forum
Matching Finnish growth companies and Chinese venture capital While international venture capital is showing growing …
Cleantech, ICT, Life Sciences, Market factors
Access to VC investment opportunities in the Baltic Sea Region
VC Zone offers both physical and networking infrastructure International VC Zone is designed for top-tier …
Prime location, Cleantech, Design & Creativity, ICT, KIBS, Life Sciences, Costs and taxes, International accessibility, Market factors
Tiny particles that can make the world of difference
Nanotechnology is multi-technological by nature as nanotechnology applications target nearly all areas of technology industries. …
Cleantech, ICT, Life Sciences, R&D&I, Skills, Nanotechnology
Helsinki based central neurosystem R&D needs international networks
Central Neurosystem disorders touch 200 billion people directly Helsinki has teams working on world-class research …
Life Sciences, R&D&I, Neuroscience
Santen Invests in Plant in Finland
Japan-based drug firm Santen Pharmaceutical Co Ltd has announced it is to invest $14 million …
Oncos Therapeutics Continues to Make Headlines as Oncolytic Virotherapy Gains Momentum
No other Finnish biotechnology start-up has made as many headlines recently as Oncos Therapeutics Ltd …
German specialty chemicals company CABB to acquire Helsinki-based KemFine Group Oy
CABB has acquired KemFine Group Oy through its Swiss subsidiary AXCABB AG for an undisclosed …
| May 21 - 22, 2012 | 7th Annual Neurotech Investing and Partnering Conference |
| Tell us about an event |
HBH sites
The Finnish Neurodegeneration Initiative
The Finnish Neurodegeneration Initiative is an interacting and marketing network that offers pre-clinical and clinical …
